Haas, Brian J. http://orcid.org/0000-0002-6609-4973
Dobin, Alexander
Li, Bo
Stransky, Nicolas
Pochet, Nathalie
Regev, Aviv
Funding for this research was provided by:
National Cancer Institute (U24CA180922, R50CA211461, R21CA209940, U01CA214846)
Article History
Received: 19 May 2019
Accepted: 28 September 2019
First Online: 21 October 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AR is a founder of and equity holder in Celsius Therapeutics and an SAB member of ThermoFisher Scientific, Neogene, and Syros Pharmaceuticals. All other authors declare that they have no competing interests.